{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:55:18Z","timestamp":1790621718829,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.euf.2021.12.003","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T01:27:23Z","timestamp":1639704443000},"page":"1520-1530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Assessment of Conservative Combination Therapies for Active and Stable Peyronie\u2019s Disease: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"8","author":[{"given":"Nikolaos","family":"Pyrgidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faysal A.","family":"Yafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Sokolakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Mykoniatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Ivan","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Verze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Hatzichristodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2021.12.003_b0005","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/j.1743-6109.2008.00895.x","article-title":"The chronology of depression and distress in men with Peyronie\u2019s disease","volume":"5","author":"Nelson","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2021.12.003_b0010","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jsxm.2016.04.062","article-title":"Evidence-based management guidelines on Peyronie\u2019s disease","volume":"13","author":"Chung","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2021.12.003_b0015","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.ijir.3900877","article-title":"Clinical presentations of Peyronie\u2019s disease","volume":"14","author":"Pryor","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.euf.2021.12.003_b0020","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","article-title":"An analysis of the natural history of Peyronie\u2019s disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie\u2019s disease: AUA guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41585-018-0117-7","article-title":"Nonsurgical management of Peyronie\u2019s disease","volume":"16","author":"Tsambarlis","year":"2019","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2021.06.007","article-title":"European Association of Urology guidelines on sexual and reproductive health\u20142021 update: male sexual dysfunction","volume":"80","author":"Salonia","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0040","series-title":"Cochrane handbook for systematic reviews of interventions","year":"2019"},{"key":"10.1016\/j.euf.2021.12.003_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.euf.2021.12.003_b0050","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2021.12.003_b0055","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ Online"},{"key":"10.1016\/j.euf.2021.12.003_b0060","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2021.12.003_b0065","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2021.12.003_b0070","doi-asserted-by":"crossref","first-page":"526","DOI":"10.5534\/wjmh.200048","article-title":"Oral administration and intralesional injection of hyaluronic acid versus intralesional injection alone in Peyronie\u2019s disease: results from a phase III study","volume":"39","author":"Cai","year":"2021","journal-title":"World J Mens Health"},{"key":"10.1016\/j.euf.2021.12.003_b0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4103\/0974-7796.152048","article-title":"Tadalafil once daily and intralesional verapamil injection: a new therapeutic direction in Peyronie\u2019s disease","volume":"7","author":"Dell\u2019Atti","year":"2015","journal-title":"Urol Ann"},{"key":"10.1016\/j.euf.2021.12.003_b0080","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.ju.0000116450.82816.2c","article-title":"A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie\u2019s disease","volume":"171","author":"Di Stasi","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0085","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/and.12178","article-title":"Combination of intralesional verapamil and oral antioxidants for Peyronie\u2019s disease: a prospective, randomised controlled study","volume":"46","author":"Favilla","year":"2014","journal-title":"Andrologia"},{"key":"10.1016\/j.euf.2021.12.003_b0090","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.acuro.2018.08.005","article-title":"Ten-year experience with multimodal treatment for acute phase Peyronie\u2019s disease: a real life clinical report","volume":"43","author":"Gallo","year":"2019","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.euf.2021.12.003_b0095","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1016\/j.urology.2011.07.1142","article-title":"Combination of andropenis penile extender and oral therapy (Peironimev) versus intralesional verpamil for penile curvature due to Peyronie\u2019s disease: preliminary results of a randomized phase II trial","volume":"78","author":"Gontero","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.euf.2021.12.003_b0100","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.urology.2005.11.005","article-title":"Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie\u2019s disease: a randomized and prospective study","volume":"67","author":"Inal","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.euf.2021.12.003_b0105","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2605.2011.01226.x","article-title":"Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie\u2019s disease and erectile dysfunction: results from a prospective randomized trial","volume":"35","author":"Palmieri","year":"2012","journal-title":"Int J Androl"},{"key":"10.1016\/j.euf.2021.12.003_b0110","first-page":"40","article-title":"The efficacy of medical treatment of Peyronie\u2019s disease: potassium para-aminobenzoate monotherapy vs. combination therapy with tamoxifen, L-carnitine, and phosphodiesterase type 5 inhibitor. World J Mens","volume":"34","author":"Park","year":"2016","journal-title":"Health"},{"key":"10.1016\/j.euf.2021.12.003_b0115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.2047-2927.2012.00007.x","article-title":"Efficacy of vitamin E in the conservative treatment of Peyronie\u2019s disease: legend or reality? A controlled study of 70 cases","volume":"1","author":"Paulis","year":"2013","journal-title":"Andrology"},{"key":"10.1016\/j.euf.2021.12.003_b0120","first-page":"1","article-title":"Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie\u2019s disease: a case-control study","volume":"8","author":"Paulis","year":"2015","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0125","first-page":"129","article-title":"Rationale of combination therapy with antioxidants in medical management of Peyronie\u2019s disease: results of clinical application","volume":"9","author":"Paulis","year":"2017","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0130","first-page":"8","article-title":"Tamoxifen only versus L-carnitine and tamoxifen in the oral therapy of Peyronie\u2019s disease","volume":"24","author":"Yoon","year":"2006","journal-title":"Korean J Androl"},{"key":"10.1016\/j.euf.2021.12.003_b0135","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1743-6109.2011.02519.x","article-title":"Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie\u2019s disease","volume":"9","author":"Abern","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2021.12.003_b0140","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.15171\/jlms.2019.S7","article-title":"Laser therapy for Peyronie\u2019s disease: a randomized control double-blind pilot study","volume":"10","author":"Allameh","year":"2019","journal-title":"J Lasers Med Sci"},{"key":"10.1016\/j.euf.2021.12.003_b0145","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jsxm.2019.03.007","article-title":"Efficacy of combined collagenase Clostridium histolyticum and RestoreX penile traction therapy in men with Peyronie\u2019s disease","volume":"16","author":"Alom","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2021.12.003_b0150","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1464-410X.2002.02738.x","article-title":"Oral propionyl-L-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie\u2019s disease","volume":"89","author":"Cavallini","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2021.12.003_b0155","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jsxm.2018.08.012","article-title":"Sildenafil 25 mg ODT + collagenase Clostridium histolyticum vs collagenase Clostridium histolyticum alone for the management of Peyronie\u2019s disease: a matched-pair comparison analysis","volume":"15","author":"Cocci","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2021.12.003_b0160","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jsxm.2019.03.163","article-title":"A prospective randomized placebo controlled study evaluating the combined effect of Low-intensity extracorporeal shockwave therapy (LI-ESWT) and vacuum erectile device on Peyronie\u2019s disease","volume":"16","author":"Mortensen","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2021.12.003_b0165","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jsxm.2017.08.015","article-title":"Treatment of Peyronie\u2019s disease with collagenase Clostridium histolyticum and vacuum therapy: a randomized, open-label pilot study","volume":"14","author":"Ralph","year":"2017","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2021.12.003_b0170","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.juro.2007.05.162","article-title":"Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie\u2019s disease: a double-blind, placebo controlled, randomized study","volume":"178","author":"Safarinejad","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0175","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.juro.2015.03.092","article-title":"The effect of duration of penile traction therapy in patients undergoing intralesional injection therapy for Peyronie\u2019s disease","volume":"194","author":"Yafi","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.urology.2017.01.054","article-title":"Clinical experience with penile traction therapy among men undergoing collagenase Clostridium histolyticum for Peyronie disease","volume":"104","author":"Ziegelmann","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.euf.2021.12.003_b0185","doi-asserted-by":"crossref","first-page":"e2036337","DOI":"10.1001\/jamanetworkopen.2020.36337","article-title":"Assessment of combination therapies vs monotherapy for erectile dysfunction: a systematic review and meta-analysis","volume":"4","author":"Mykoniatis","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euf.2021.12.003_b0190","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.sxmr.2020.07.008","article-title":"Surgical planning and strategies for Peyronie\u2019s disease","volume":"9","author":"Almeida","year":"2021","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.euf.2021.12.003_b0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jsxm.2018.12.011","article-title":"Comparative effectiveness of intralesional therapy for Peyronie\u2019s disease in controlled clinical studies: a systematic review and network meta-analysis","volume":"16","author":"Russo","year":"2019","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2021.12.003_b0200","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.sxmr.2020.01.005","article-title":"Review of intralesional collagenase Clostridium histolyticum injection therapy and related combination therapies in the treatment of Peyronie\u2019s disease (an update)","volume":"9","author":"Natale","year":"2021","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.euf.2021.12.003_b0205","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.sxmr.2018.02.005","article-title":"Penile traction therapy and vacuum erection devices in Peyronie\u2019s disease","volume":"7","author":"Avant","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.euf.2021.12.003_b0210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.sxmr.2018.09.007","article-title":"Review of management options for active-phase Peyronie\u2019s disease","volume":"7","author":"Brimley","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.euf.2021.12.003_b0215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase Clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0220","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.eururo.2019.11.019","article-title":"The end of an era: withdrawal of Xiapex (Clostridium histolyticum collagenase) from the European market","volume":"77","author":"Cocci","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0225","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.eururo.2018.07.005","article-title":"Clinical efficacy of injection and mechanical therapy for Peyronie\u2019s disease: a systematic review of the literature","volume":"74","author":"Russo","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ijir.2016.24","article-title":"A meta-analysis of extracorporeal shock wave therapy for Peyronie\u2019s disease","volume":"28","author":"Gao","year":"2016","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.euf.2021.12.003_b0235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrurol.2010.233","article-title":"Current status of the surgical management of Peyronie\u2019s disease","volume":"8","author":"Kadioglu","year":"2011","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0240","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.21037\/tau-20-1236","article-title":"A comprehensive narrative review of residual curvature correction during penile prosthesis implantation in patients with severe erectile dysfunction and concomitant Peyronie\u2019s disease","volume":"10","author":"Sokolakis","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0245","article-title":"Penile prosthesis implantation combined with grafting techniques in patients with Peyronie\u2019s disease and erectile dysfunction: a systematic review","author":"Sokolakis","year":"2021","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.euf.2021.12.003_b0250","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/JU.0000000000001933","article-title":"Suture-free sealing of tunical defect with collagen fleece after partial plaque excision in 319 consecutive patients with Peyronie\u2019s disease: the sealing technique","volume":"206","author":"Hatzichristodoulou","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.12.003_b0255","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.euf.2018.08.026","article-title":"Surgical management of Peyronie\u2019s disease","volume":"4","author":"Patel","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2021.12.003_b0260","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1111\/j.1743-6109.2012.02849.x","article-title":"A retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie\u2019s disease: measured lengths and patient perceptions","volume":"9","author":"Rybak","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.euf.2021.12.003_b0265","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41443-020-0247-3","article-title":"A modern review of penile traction monotherapy and combination therapy for the treatment of Peyronie\u2019s disease","volume":"33","author":"Bole","year":"2021","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.euf.2021.12.003_b0270","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.sxmr.2018.11.002","article-title":"Penile stretching as a treatment for Peyronie\u2019s disease: a review","volume":"7","author":"Cowper","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.euf.2021.12.003_b0275","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.urology.2018.07.039","article-title":"The effect of adjunct mechanical traction on penile length in men undergoing primary treatment for Peyronie\u2019s disease: a systematic review and meta-analysis","volume":"122","author":"Haney","year":"2018","journal-title":"Urology"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456921003138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456921003138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:53:01Z","timestamp":1762498381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456921003138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2405456921003138"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2021.12.003","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Conservative Combination Therapies for Active and Stable Peyronie\u2019s Disease: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2021.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}